The Dysbiosis Triggered by First-Line Tuberculosis Antibiotics Fails to Reduce Their Bioavailability
ABSTRACT Antituberculosis therapy (ATT) causes a rapid and distinct alteration in the composition of the intestinal microbiota that is long lasting in both mice and humans. This observation raised the question of whether such antibiotic-induced changes in the microbiome might affect the absorption o...
Main Authors: | Sivaranjani Namasivayam, Matthew Zimmerman, Sandra Oland, Han Wang, Lara R. Mittereder, Véronique Dartois, Alan Sher |
---|---|
Format: | Article |
Language: | English |
Published: |
American Society for Microbiology
2023-04-01
|
Series: | mBio |
Subjects: | |
Online Access: | https://journals.asm.org/doi/10.1128/mbio.00353-23 |
Similar Items
-
Longitudinal profiling reveals a persistent intestinal dysbiosis triggered by conventional anti-tuberculosis therapy
by: Sivaranjani Namasivayam, et al.
Published: (2017-07-01) -
The Microbiome and Tuberculosis: Early Evidence for Cross Talk
by: Sivaranjani Namasivayam, et al.
Published: (2018-11-01) -
Correlation between Disease Severity and the Intestinal Microbiome in <named-content content-type="genus-species">Mycobacterium tuberculosis</named-content>-Infected Rhesus Macaques
by: Sivaranjani Namasivayam, et al.
Published: (2019-06-01) -
Evaluation of the multiple doses thiozonide’s pharmacokinetics in patients diagnosed with pulmonary tuberculosis with multidrug-resistant or extensively drug-resistant <i>Mycobacterium tuberculosis</i>
by: А. Yu. Savchenko, et al.
Published: (2024-01-01) -
The gut microbiome influences the bioavailability of olanzapine in rats
by: Sofia Cussotto, et al.
Published: (2021-04-01)